Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition
A blocking peptide from NIPBL .
Synthetic
The NIPBL Blocking Peptide has been validated for the following applications: Antibody Competition.
| Marque | Novus Biologicals |
|---|---|
| Réf. B-LABO | BL-RE-055269 |
| Réf. fabricant | 18065597 |
| Gene ID (Entrez) | 25836 |
| Espèces | Human |
| Pureté | >95% |
| Numéro d’adhésion | Q6KC79 |
| Contenu et stockage | Store at -20 C short term. Aliquot and store (at -80 C long term. Avoid freeze-thaw cycles.) |
| Formule | 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 |
| À utiliser avec (application) | This product should be used at 1.0μg per 1.0μL of antiserum in per assay. |
| Alias de gène | CDLS1, delangin, DKFZp434L1319, FLJ11203, FLJ12597, FLJ13354, FLJ13648, FLJ44854, IDN3-B, IDN3CDLS, Nipped-B homolog (Drosophila), nipped-B-like protein, Scc2, SCC2 homolog, sister chromatid cohesion 2 homolog |
| Symbole de gène(s) | NIPBL |
| Type de produit | NIPBL Peptide |
| Quantité | 0.05 mg |
| État réglementaire | RUO - research use only |
| Source | Synthetic |
